metabolic side effects

New Research from the CWMH: Omega-3 Fatty Acids for Atypical Antipsychotic-Associated Hypertriglyceridemia

Dyslipidemia is a common side effect of atypical antipsychotics and, for a significant number of patients, may limit the acceptabillily of this class of drugs as an option for long-term treatment. This open trial tested [...]

By |2016-03-29T15:29:06-04:00August 1st, 2015|Alternative & Complementary, Antipsychotic Medications, Research at CWMH|Comments Off on New Research from the CWMH: Omega-3 Fatty Acids for Atypical Antipsychotic-Associated Hypertriglyceridemia

Use of Antipsychotic Medications in Pregnancy Increases Risk of Gestational Diabetes

Atypical antipsychotic medications are commonly used for the treatment of schizophrenia and bipolar disorder.  Despite the increasing use of these medications in women of child-bearing age, there is still relatively little data regarding the reproductive safety of these medications. 

By |2024-04-14T16:18:01-04:00July 17th, 2012|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Pregnancy Outcomes|Comments Off on Use of Antipsychotic Medications in Pregnancy Increases Risk of Gestational Diabetes

Screening for Metabolic Side Effects of Atypical Antipsychotics

Atypical antipsychotics are increasingly used to treat psychiatric disorders such as bipolar disorder or schizophrenia.  In spite of the important role they play for many patients in treating serious psychiatric disorders, atypicals have been associated with negative side effects that may worsen a patient's cardiovascular health profile.  This includes a greater risk for weight gain, glucose dysregulation/diabetes, and dyslipidemia (elevated triglycerides/cholesterol).

By |2015-08-12T14:17:19-04:00March 31st, 2009|Antipsychotic Medications, General, Outcomes|Comments Off on Screening for Metabolic Side Effects of Atypical Antipsychotics
Go to Top